Home/Filings/4/0001247319-05-000062
4//SEC Filing

CYTYC CORP 4

Accession 0001247319-05-000062

CIK 0000849778operating

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 11:40 AM ET

Size

8.6 KB

Accession

0001247319-05-000062

Insider Transaction Report

Form 4
Period: 2005-09-09
LINDER JAMES
Sr. VP, Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2005-09-09$25.75/sh5,000$128,7632,663 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2005-09-095,00010,000 total
    Exercise: $0.83From: 1999-12-14Exp: 2005-12-14Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2005-09-09$0.83/sh+5,000$4,1677,663 total
Footnotes (3)
  • [F1]Granted pursuant to Issuer's 1989 Stock Plan and exempt from Section 16 pursuant to Rule 16b-3.
  • [F2]The sale reported on this Form 4 was made pursuant to a written trading plan adopted in accordance with SEC Rule 10b5-1 on February 11, 2005.
  • [F3]Price not applicable to this transaction.

Issuer

CYTYC CORP

CIK 0000849778

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000849778

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 11:40 AM ET
Size
8.6 KB